Molecule Details
| InChIKey | FZBAOOQVQXATRL-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | N#Cc1cc(Cl)cc(Oc2c(Cl)ccc3c2cnn3Cc2n[nH]c3ncccc23)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 9.23 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12999 |
|---|---|
| Drug Name | MK-6186 |
| CAS Number | 1034474-19-5 |
| Groups | investigational |
| ATC Codes | nan |
| Description | MK6186 has been used in trials studying the treatment of HIV-1 Infection. |
Cross-references: CHEMBL1939499 ChemSpider: 28424190 PubChem:24988948 PubChem:347829136 ZINC: ZINC000073240561
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P03366 | gag-pol | Gag-Pol polyprotein | inhibitor | targets |